SYDNEY, 5 November 2025 Global professional services firm Alvarez & Marsal (A&M) today released fresh insights into Australia’s private debt market. Its latest Australian Private Debt Market Review 2025 reveals a robust growth trajectory as assets under management reach A$224 billion - a strong 9% increase from 2024.

Australia’s private debt market has surged past A$224 billion in assets under management, marking a pivotal shift in financial momentum.

Residential solar is entering a new phase, where growth depends less on hardware and more on collaboration. A&M explores how strategic partnerships can reduce costs, accelerate installs, and reshape the economics of energy.

For most companies, real estate is not a core business, but nearly every enterprise must actively manage their real assets even though doing so is a complex task. With the right strategy in place, managing corporate real estate can positively impact EBITDA.

This article explores the implications of e-Invoicing changes in Germany, with a particular focus on validation as the new compliance backbone.

In this Q3 2025 edition of our VAT Quarterly Wrap-up, we address three VAT topics which kept the CJEU busy in the third quarter of 2025. Alongside these cases, we selected a number of developments relevant for companies active in EU Member States.

Explore the restrictive interpretation of third party debt in Australia's PCG 2025/2, with minimal concessions and a hardline approach by the Commissioner.

Managing Director Rich Behrens has been selected as an honoree for the American Bankruptcy Institute’s (ABI) 2025 “40 Under 40” Award.

With the FDA’s disclosure of 200 Complete Response Letters (CRLs), leadership teams now have an unprecedented insight into regulatory decision-making to glean patterns, challenge assumptions, and strengthen governance before avoidable failures occur.

Keystone Asset Management Ltd - A&M AUS Insolvency Portal

Discover the latest trends shaping the turnaround profession and Australia’s broader economy in A&M's 2025 Annual Turnaround Survey in partnership with the TMA.

Explore transfer pricing challenges in the pharmaceutical sector, shaped by high profitability, R&D investments, patent protections, and marketing intangibles.

CRA states that holding foreign, personal use property may prevent taxpayers from relying on “domestic exemption” from EIFEL.